Scopolamine Market Size

Scopolamine Market size was valued at USD 486.02 Billion in 2023 and is poised to cross USD 939.42 Billion by 2036, expanding at more than 5.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of scopolamine is estimated at USD 510.04 Billion. The growth of the market can be attributed to the growing number of surgeries across the world. The number of surgeries performed worldwide every year was estimated to be over 300 million as of 2020. The increasing application of scopolamine motion sickness is estimated to drive market growth. The increasing awareness of people regarding the benefits of scopolamine is projected to fuel market growth in the coming years.

The number of people traveling around the world is expected to boost market growth. Many travelers suffer from motion sickness which causes vomiting and nausea during the journey. Scopolamine helps to prevent the feeling of nausea by blocking the nerves with an anticholinergic effect. The increasing use in people suffering from vertigo which cause severe headache and then vomiting is estimated to boost the market growth in the coming years. More than 40% of Americans suffer from vertigo once during their life as per the estimations in 2021.